What GPs need to know about palliative-care drugs: ketamine

Full text not archived in this repository.

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Howard, R. L. and Howard, P. D. (2012) What GPs need to know about palliative-care drugs: ketamine. Prescriber, 23 (12). pp. 43-46. ISSN 0959-6682 doi: 10.1002/psb.933

Abstract/Summary

This is the first in a short series of articles that focus on what GPs should consider when monitoring and prescribing specialist-initiated palliative-care drugs. This first article summarises the key issues for patients receiving ketamine.

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/28907
Identification Number/DOI 10.1002/psb.933
Refereed Yes
Divisions Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Pharmacy Practice Research Group
Publisher Wiley
Download/View statistics View download statistics for this item

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar